Abzena

About Abzena

Abzena is a bioconjugate- and biologics-focused CDMO that pushes development of novel treatments forward at every stage from discovery through commercial launch. With the ability to tailor its strategy and customer experience to each project, Abzena develops and implements innovative solutions that enable biotech and biopharma companies to realize the full potential of their investments in human h...

  • US
  • 2018
    On CPHI since
Contact info

Abzena Resources (1)

  • News CPHI Podcast Series: Designing Drug Conjugates

    Digital Editor Lucy Chard goes through the bioconjugate journey in this latest podcast from the CPHI Podcast Series, from development to manufacturing, with two experts in the field from Abzena, Louise Duffy and Campbell Bunce.